ArticleOncology letters2026
Primary thyroid lymphoma with Hashimoto's thyroiditis: A case report and literature review.
Article in Oncology letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary thyroid diffuse large B-cell lymphoma (DLBCL) represents a rare and diagnostically challenging malignancy, particularly when arising in the setting of pre-existing Hashimoto's thyroiditis (HT). The present case report describes the case of an 86-year-old female patient with primary thyroid lymphoma (PTL) who presented with life-threatening tracheal compression. The aim of this report is to emphasize the diagnostic challenges due to overlapping clinical features with thyroid carcinoma and the absence of consensus management guidelines. Following ultrasound-guided biopsy and immunohistochemical analysis, germinal center-originated DLBCL was confirmed. The patient received four cycles of zuberitamab (a novel anti-CD20 monoclonal antibody) plus mini-CHOP therapy, with CT imaging demonstrating notable tracheal re-expansion after the first cycle. Successful disease control and quality of life were maintained throughout the follow-up. Furthermore, a comprehensive literature review was performed to elucidate the clinical manifestations and therapeutic approaches of PTL. In conclusion, the present case exemplifies that elderly patients with rapidly enlarging neck masses require urgent evaluation to distinguish between thyroid lymphoma and carcinoma. While individual case results cannot be generalized to all clinical scenarios, prompt diagnosis followed by appropriate treatment remains critical for favorable outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.